• By ICR Secretariat
  • Posted Thursday, March 25, 2021

AstraZeneca, Oxford vaccine prevents COVID-19 in big US study amid controversy overseas

https://www.biopharmadive.com/news/astrazeneca-oxford-vaccine-us-efficacy-results/596891/

A two-shot regimen was 79% effective at protecting people from COVID-19, which should support the fourth clearance of a vaccine in the U.S. and calm safety concerns abroad.